NCT06365645

Brief Summary

Postpartum depression (PPD) affects up 10-15% of mothers overall, but the rate of PPD can be as high as 25% among mothers with personal or obstetric risk factors. The Mothers \& Babies Program (MB) is a cognitive behavioral therapy (CBT)-based program that has been shown to prevent PPD among high-risk mothers without a prior history of depression. MB has been so consistently effective that the United States Preventive Services Task Force recommends this program be given to high-risk pregnant patients. Originally designed to be given in-person and via groups, MB has been adapted to be given in person one-on-one in clinic or at home and via text message. However, MB has yet to be adapted to a smartphone application (app). Via evidence-based qualitative research and end-user centered design, MB has been adapted to a novel app, M.Bapp. This study aims to examine the feasibility and acceptability of M.Bapp as a study intervention for perinatal patients as well as provide preliminary estimates of effect for the intervention.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 7, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

1.2 years

First QC Date

April 9, 2024

Last Update Submit

June 23, 2025

Conditions

Keywords

perinatal mental healthdigital healthpostpartum depressionpostpartum anxietysmartphone application (app)

Outcome Measures

Primary Outcomes (2)

  • Feasibility

    50% of those who are eligible based on prescreening and who are approached to participate consent to participate and 80% of those randomized to M.Bapp view at least 5 of the 10 modules

    Randomization and six months postpartum

  • Acceptability

    Scoring at least 80% on two well-validated scales: the System Usability Scale (focusing on perceived usability of technology) and the Client Satisfaction Questionnaire (focusing on satisfaction with mental health therapy). These surveys will also contain questions covering additional themes about participant experience with the study intervention (either M.Bapp or app-based parenting education)-(1) helpfulness; (2) satisfaction; and (3) ease of interface with technical aspects of the program.

    Six months postpartum

Secondary Outcomes (6)

  • Inventory for Depression Scale

    Baseline (32-36 weeks' gestation), within one week of delivery, 2 months postpartum, 4 months postpartum, and 6 months postpartum

  • General Anxiety Disorder-7

    Baseline (32-36 weeks' gestation), within one week of delivery, 2 months postpartum, 4 months postpartum, and 6 months postpartum

  • Perceived Stress-Scale 4

    Baseline (32-36 weeks' gestation), 2 months postpartum, and 6 months postpartum

  • Dyadic Adjustment Scale

    Baseline (32-36 weeks' gestation), 2 months postpartum, and 6 months postpartum

  • UCLA Loneliness Scale

    Baseline (32-36 weeks' gestation), 2 months postpartum, and 6 months postpartum

  • +1 more secondary outcomes

Other Outcomes (2)

  • De novo psychiatric diagnosis

    Within one week of delivery, 2 months postpartum, 4 months postpartum, and 6 months postpartum

  • Screening positive on study survey

    Within one week of delivery, 2 months postpartum, 4 months postpartum, and 6 months postpartum

Study Arms (2)

App-based digital parenting education

ACTIVE COMPARATOR

App-based digital parenting education will be delivered through a smartphone app with similar features as M.Bapp, but the content delivered through this attention-matched control app will not contain any CBT modules or psychoeducation.

Behavioral: App-based parenting education

M.Bapp

EXPERIMENTAL

M.Bapp contains the same app-based digital parenting education provided to the active comparator group as well as 9 additional interactive modules based on the MB cognitive behavioral therapy curriculum. M.Bapp contains interactive features and EMA-based voluntary daily assignments that provide the opportunity to receive additional final reimbursement. Those who complete all modules will receive a digital certificate of completion.

Behavioral: M.Bapp

Interventions

M.BappBEHAVIORAL

Please see experimental group description.

M.Bapp

Please see active comparator group description.

App-based digital parenting education

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients must be pregnant in order to participate
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • English- or Spanish-speaking
  • maternal age \>18 years old
  • smartphone ownership
  • receiving prenatal care from a resident or nurse-practitioner/midwifery clinic at the Obstetric and Gynecologic Care Center at WIH
  • plan to receive postpartum care at the OGCC,
  • gestational age ≥32 weeks'.

You may not qualify if:

  • Active diagnosis or history within five years of depression, anxiety, or other psychiatric condition, as documented in the electronic medical record
  • Endorsing active suicidality on intake survey or screening positive on EPDS (≥10) or Patient Health Questionnaire (PHQ)-9 (≥10) or GAD-7 (≥8)
  • prisoners
  • inability to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

MeSH Terms

Conditions

Depression, PostpartumAlzheimer Disease

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants who consent will be unaware of the existence of another version of M.Bapp. Obstetric care providers will be aware of participant's enrollment in this trial but not of the study group and will be encouraged to provide standardized care. The research team and outcomes assessors will be blindd to the randomization group.
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 15, 2024

Study Start

June 7, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Data from this small pilot will not be made available to other researchers

Locations